The heart scan that keeps almost arriving

Magnetocardiography reads the faint magnetic field thrown off by the heart's own electrical activity, without touching the patient. It is around sixty years old, it keeps producing evidence that it sees things a standard ECG cannot, and it is still not accepted as a routine clinical tool. The gap between those last two facts is where quantum medicine actually lives.

The record is laid out by the people who have lived it. In a 2023 review in Frontiers in Cardiovascular Medicine, Brisinda, Fenici and Fenici, whose group has worked on the technique since the early 1980s, write that a large body of research and several clinical trials have shown magnetocardiography reliably supplies diagnostic electrophysiological information beyond what conventional non-invasive electrocardiographic methods provide. Because the sensors sit outside the body, the signal escapes the distortion that skin, fat, muscle and bone impose on readings taken at the surface.

So why is it not in the emergency department down the road? Noise. The magnetic signal of a beating heart is minuscule beside the magnetic clutter of an urban hospital, and for decades the answer was a shielded room that only a handful of institutions could afford to run. That constraint is loosening. In March 2019 the Ohio company Genetesis announced FDA 510(k) clearance for a magnetocardiograph whose optically pumped magnetometers removed the liquid-helium cooling that had chained the method to specialized facilities. A year earlier, Physics World reported a five-site American trial across Mayo Clinic, Baylor, Vanderbilt, the University of Cincinnati and Wake Forest, enrolling roughly 720 emergency patients with chest pain. In 2024, Fierce Healthcare reported a Mayo Clinic study with SandboxAQ, about 150 patients through 2025, comparing room-temperature sensors, in an approach the company calls quantum sensing, against angiography.

The computational side of quantum medicine runs on a different clock. This January, Scientific Reports carried a quantum denoising autoencoder for retinal fundus images, built for earlier screening of diabetic retinopathy, which its authors place among the most common causes of irreversible blindness worldwide; their starting point is that classical filters smooth away the very microaneurysms a diagnosis leans on. Two weeks before it, the same journal published a large-scale statistical comparison of quantum and classical neural networks in medicine, and it is admirably candid about the ceiling: today's devices carry a minimal number of noisy qubits, which leaves known quantum algorithms for practical problems out of reach on today's machines.

Hold both clocks side by side and the picture sharpens. Quantum sensing is at the door of the bedside, with a clearance and multicenter trials behind it. Quantum computation in medicine is doing careful work inside a hardware limit its own literature names out loud. Chest pain alone drives on the order of 6.5 million American emergency-department encounters a year, on the figure Fierce Healthcare cites, so the value of getting the first of those right is considerable. The question worth asking about either is the same: what does the accumulated record support today, and where does it stop?

Primary source: Brisinda, Fenici & Fenici, Frontiers in Cardiovascular Medicine, 2023. Also drawn on: Scientific Reports, January 2026; EurekAlert!, March 2019; Physics World, July 2018; Fierce Healthcare, August 2024.

Following all of this is a full-time job, and it does not have to be yours. The Evidence Register keeps the picture of quantum medicine current for you, in plain language, with the sources at your elbow, so you can walk into any meeting knowing where things really stand.